CRM
52
2
MLM
63
3
O
57
2
FTI
84
3
VZ
54
2
APD
55
3
FAST
46
4
CL
59
-3
PPL
57
-2
NSC
64
2
OI
50
-5
OKE
56
3
AMG
77
2
PVH
64
5
LRCX
65
10
DTE
43
3
AMP
67
3
MS
76
3
SLB
44
5
MOS
26
-3
CRM
52
2
MLM
63
3
O
57
2
FTI
84
3
VZ
54
2
APD
55
3
FAST
46
4
CL
59
-3
PPL
57
-2
NSC
64
2
OI
50
-5
OKE
56
3
AMG
77
2
PVH
64
5
LRCX
65
10
DTE
43
3
AMP
67
3
MS
76
3
SLB
44
5
MOS
26
-3
Financhill
Back

Amphastar Pharmaceuticals, Inc. 10K Form

Buy
56

AMPH
Amphastar Pharmaceuticals, Inc.

Last Price:
$27.12
Seasonality Move:
2.09%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AMPH News And Ratings

See the #1 stock for the next 7 days that we like better than AMPH

AMPH Financial Statistics

Sales & Book Value

Annual Sales: $732M
Cash Flow: $47.2M
Price / Cash Flow: 12.05
Annual Sales: $16.76
Price / Book: 1.61

Profitability

EPS (TTM): 2.25530
Net Income (TTM): $111.6M
Gross Margin: $361.4M
Return on Equity: 14.9%
Return on Assets: 6.91%

Amphastar Pharmaceuticals, Inc. Earnings Forecast

Key Amphastar Pharmaceuticals, Inc. Financial Ratios

  • The Gross Profit Margin over the past 22 years for AMPH is 49.37%.
  • The Selling, General & Administrative Expenses for AMPH have been equal to 12.91% of Gross Profit Margin.
  • The Research & Development expenses have been 8.39% of Revenue.
  • The Interest Expense is 19.02% of Operating Income.
  • The Net Earning history of AMPH is 21.79% of Total Revenues.
  • Per Share Earnings over the last 22 years have been positive in 11 years.

Amphastar Pharmaceuticals, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: AMPH
CUSIP: 03209R
Website: amphastar.com

Debt

Debt-to-Equity Ratio: 0.85
Current Ratio: 3.12
Quick Ratio: 2.07

Price-to-Earnings

Trailing P/E Ratio: 8.86
Forward P/E Ratio: 7.44

AMPH Technical Analysis vs Fundamental Analysis

Buy
56
Amphastar Pharmaceuticals, Inc. (AMPH) is a Buy

Is Amphastar Pharmaceuticals, Inc. a Buy or a Sell?